ArticleEuropean journal of microbiology & immunology2024

Preclinical assessment of a recombinant RBD-Fc fusion protein as SARS-CoV-2 candidate vaccine.

Navid Dashti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.